Clinical Trial Update: An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 trial exploring gene therapy 4D-310 in adults with Fabry disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• 4D-310

Snippet

Sponsor: 4D Molecular Therapeutics | Conditions: Fabry Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING